Annalisa Jenkins, MBBS, FRCP.

Non-Executive Director

Annalisa is a thought leader with over 25 years of biopharmaceutical experience. She served as CEO of Dimension Therapeutics, a gene therapy company acquired by Ultragenyx. Prior roles include Head of Global R&D at Merck Serono. She currently serves on a number of public and private boards globally.